Haleon plc (LON:HLN) Insider Blathnaid Bergin Purchases 6,145 Shares

Haleon plc (LON:HLN) insider Blathnaid Bergin bought 6,145 shares of Haleon stock in a transaction dated Friday, May 16th. The stock was acquired at an average price of GBX 404 ($5.37) per share, for a total transaction of £24,825.80 ($33,013.03).

Haleon Trading Up 0.2%

Shares of Haleon stock opened at GBX 404.71 ($5.38) on Monday. The stock has a market cap of £36.53 billion, a PE ratio of 34.04, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The firm has a fifty day moving average price of GBX 385.85 and a 200 day moving average price of GBX 381.30. Haleon plc has a 1 year low of GBX 319.84 ($4.25) and a 1 year high of GBX 417.70 ($5.55). The company has a debt-to-equity ratio of 53.36, a current ratio of 0.84 and a quick ratio of 0.93.

Haleon (LON:HLN) last posted its quarterly earnings data on Friday, February 28th. The company reported GBX 15.80 ($0.21) earnings per share (EPS) for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. Equities research analysts predict that Haleon plc will post 19.5033282 earnings per share for the current year.

Haleon Increases Dividend

The business also recently declared a dividend, which will be paid on Thursday, June 5th. Shareholders of record on Thursday, April 24th will be given a dividend of GBX 4.60 ($0.06) per share. The ex-dividend date of this dividend is Thursday, April 24th. This is a boost from Haleon’s previous dividend of $2.00. This represents a dividend yield of 1.18%. Haleon’s dividend payout ratio (DPR) is currently 50.46%.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank boosted their price target on shares of Haleon from GBX 456 ($6.06) to GBX 457 ($6.08) and gave the company a “buy” rating in a report on Friday, February 28th.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.